In vitro experiments have shown that up-regulation of TPX2 expression activates EMT and promotes the expression and activity of matrix metalloproteinase-2 (MMP2) and MMP9, thereby increasing the migration and invasiveness of NSCLC cells [18]. Here, TPX2 is linked to non-small cell lung carcinoma.